By Hilgo Bruining (University Medical Center, Amsterdam, the Netherlands). November 7th, 2022. New treatment developments for neurodevelopmental such as autism have failed to reach clinical implementation due to inter- and intraindividual variability across biological and clinical dimensions. To resolve this situation, we propose to use the framework of excitation/inhibition imbalances in resting-state EEG measurements to … Continue reading Spotlight 2022#1 – Hilgo BRUINING – Criticality at the core of precision medicine for neurodevelopmental disorders